Skip to main content

BPH Global Ltd (BP8.AX)

Australian Securities Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
37.6Poor

ValueMarkers Composite Index

Top 3%#43,456 of 44,714

DCF data not available

Piotroski
5/9
Neutral
Beneish
-2.56
Low Risk
Altman
-226.31
Distress
DCF Value
-
N/A
ROIC
99.4%
Strong
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

BPH Global Ltd (BP8.AX) — VMCI valuation read

Across 120 indicators, BPH Global Ltd (BP8.AX) lands at VMCI 38/100. The Healthcare sector median is 50, so the 12-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on BP8.AX in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, BP8.AX trades at 25.0x earnings, 39% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%). On Risk, net debt to EBITDA of 3.5x is the binding constraint on the bear case for BP8.AX on the trailing balance sheet.

BP8.AX fell 3.0% over the trailing 7 days, with a -22.3% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in BP8.AX’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.